Article 13 Oct 2021 In The Orphan Drug Approval Race, Winner Takes All? Ramifications Of Catalyst Pharms. V. Becerra United States Healthcare
Article 13 Sep 2021 Ownership Of Inventions By Former Employers: Lessons After Bio-Rad v. ITC United States IP
Article 27 Jul 2021 "Advancing Education On Biosimilars": Game Changer Or More Of The Same? United States Healthcare
Article 23 Nov 2020 H.R. 4712: A "Narrowly Tailored" Obligation Under The Orphan Drug Act? United States Healthcare
Article 01 Oct 2020 Pre-Election Drug Pricing Regulation Efforts: Where Does Congress Stand? United States Healthcare
Article 29 Sep 2020 Orphan Drug Exclusivity For CRISPR/Cas-Based Therapeutics United States Healthcare
Article 15 Sep 2020 HHS Can't Force Disclosure Of Drug Prices In Ads With "Blunderbuss" Rule United States Healthcare
Article 30 Mar 2020 Bipartisan Congress Intensifies Efforts To Restrict Orphan Drug Exclusivity United States Healthcare